These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2372058

  • 21. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
    Zhou W, Chao W, Levine BA, Olson MS.
    Am J Physiol; 1992 Nov; 263(5 Pt 1):G587-92. PubMed ID: 1443133
    [Abstract] [Full Text] [Related]

  • 22. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
    Konturek SJ, Brzozowski T, Drozdowicz D, Garlicki J, Beck G.
    Eur J Pharmacol; 1989 May 19; 164(2):285-92. PubMed ID: 2759176
    [Abstract] [Full Text] [Related]

  • 23. Protective effects of somatostatin against gastric damage induced by hemorrhagic shock, stress and PAF in the rat.
    Wallace JL, Boichot E, Sidoti C, Brecx A, Paubert-Braquet M.
    Regul Pept; 1993 Sep 03; 47(2):195-203. PubMed ID: 7901873
    [Abstract] [Full Text] [Related]

  • 24. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma.
    Faden AI, Tzendzalian PA.
    Am J Physiol; 1992 Oct 03; 263(4 Pt 2):R909-14. PubMed ID: 1415805
    [Abstract] [Full Text] [Related]

  • 25. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA, Magnusson JE, Wurtman RJ.
    Psychopharmacology (Berl); 2002 Oct 03; 163(3-4):430-3. PubMed ID: 12373444
    [Abstract] [Full Text] [Related]

  • 26. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats.
    Kirejczyk JK, Chyczewski L, Debek W.
    Rocz Akad Med Bialymst; 1995 Oct 03; 40(1):65-76. PubMed ID: 8528996
    [Abstract] [Full Text] [Related]

  • 27. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M, Hosford D, Braquet P.
    J Lipid Mediat; 1993 Oct 03; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract] [Full Text] [Related]

  • 28. Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
    Zhou WG, Chao W, Levine BA, Olson MS.
    Am J Pathol; 1990 Dec 03; 137(6):1501-8. PubMed ID: 1701964
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Oct 03; 255(1):256-63. PubMed ID: 2213560
    [Abstract] [Full Text] [Related]

  • 31. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
    Martins MA, Etienne A, Soulard C, Domingo MT, Braquet P.
    Braz J Med Biol Res; 1989 Oct 03; 22(9):1151-4. PubMed ID: 2636011
    [Abstract] [Full Text] [Related]

  • 32. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S, Redl H, Thurnher M, Vogl C, Paul E, Schiesser A, Schlag G.
    Prog Clin Biol Res; 1989 Oct 03; 308():931-6. PubMed ID: 2780740
    [No Abstract] [Full Text] [Related]

  • 33. Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain.
    Kochanek PM, Melick JA, Schoettle RJ, Magargee MJ, Evans RW, Nemoto EM.
    Stroke; 1990 Mar 03; 21(3):459-62. PubMed ID: 2309270
    [Abstract] [Full Text] [Related]

  • 34. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
    Hatakeyama K, Yano S, Watanabe K.
    Jpn J Pharmacol; 1991 Jul 03; 56(3):271-7. PubMed ID: 1910120
    [Abstract] [Full Text] [Related]

  • 35. [Platelet-activating factor (PAF) antagonists].
    Terasawa M.
    Tanpakushitsu Kakusan Koso; 1991 Feb 03; 36(3):379-87. PubMed ID: 1850862
    [No Abstract] [Full Text] [Related]

  • 36. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
    Sirén AL, Feuerstein G.
    Am J Physiol; 1989 Jul 03; 257(1 Pt 2):H25-32. PubMed ID: 2546449
    [Abstract] [Full Text] [Related]

  • 37. Evidence against a role for platelet-activating factor in hypoxic pulmonary vasoconstriction in the rat.
    McCormack DG, Barnes PJ, Evans TW.
    Clin Sci (Lond); 1989 Oct 03; 77(4):439-43. PubMed ID: 2805602
    [Abstract] [Full Text] [Related]

  • 38. Mast cell activation augments gastric mucosal injury through a leukotriene-dependent mechanism.
    Rioux KP, Wallace JL.
    Am J Physiol; 1994 May 03; 266(5 Pt 1):G863-9. PubMed ID: 8203531
    [Abstract] [Full Text] [Related]

  • 39. Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.
    Esplugues JV, Whittle BJ.
    Br J Pharmacol; 1988 Jan 03; 93(1):222-8. PubMed ID: 3349230
    [Abstract] [Full Text] [Related]

  • 40. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021.
    Debek W, Gruca P, Chyczewski L, Gruca A.
    Rocz Akad Med Bialymst; 1995 Jan 03; 40(1):129-37. PubMed ID: 8528982
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.